Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 150 mg

Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 225 mg

Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - ivermectin - tabletter - 3 mg

Európai Unió - dán - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - fesoterodinfumarat - depottabletter - 4 mg

Európai Unió - dán - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.

Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - sildenafilcitrat - filmovertrukne tabletter - 100 mg

Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

medical valley invest ab - sildenafilcitrat - filmovertrukne tabletter - 50 mg

Európai Unió - dán - EMA (European Medicines Agency)

glaxosmithkline trading services limited - fluticasonfuroat, umeclidiniumbromid, vilanteroltrifenat - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - temybric ellipta er angivet som en vedligeholdelsesbehandling hos voksne patienter med moderat til svær kronisk obstruktiv lungesygdom (kol), der ikke er tilstrækkeligt behandlet ved en kombination af en inhaleret binyrebarkhormon og langtidsvirkende β2-agonist eller en kombination af en langtidsvirkende β2-agonist og en langtidsvirkende muskarine antagonist (for indvirkning på symptom kontrol og forebyggelse af eksacerbationer se afsnit 5.

Európai Unió - dán - EMA (European Medicines Agency)

virbac s.a. - clomipramine hydrochloride - psychoanaleptics - hunde - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.